Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients
NCT01363232
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
89
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
Selected Solid Tumors
Interventions
DRUG:
BKM120 + MEK162
Sponsor
Array Biopharma, now a wholly owned subsidiary of Pfizer